StockWatch
·
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Board MeetingJul 30, 2026, 08:03 AM

Intellia Therapeutics Schedules Q2 2026 Earnings Call for August 6

AI Summary

Intellia Therapeutics, Inc. announced it will host a conference call on August 6, 2026, at 8 a.m. ET. The purpose of the call is to discuss the company's second quarter 2026 financial results and provide business updates. Investors can access the call via webcast or teleconference, with replay available for approximately 90 days.

Key Highlights

  • Intellia Therapeutics to host a conference call on August 6, 2026.
  • The call will discuss second quarter 2026 financial results and business updates.
  • The conference call is scheduled for 8 a.m. ET.
  • Webcast access available via a provided link.
  • Teleconference dial-in numbers provided for U.S. and international callers.